Patent · US Active

Detection of platelet-derived shed CD31

US9534036B2 · kind B2 · utility

2Cited by

0References

14Claims

0Family size

Assignees

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
UNIVERSITÉ PARIS DIDEROT—PARIS 7 · FR
UNIVERSITE PARIS 13 - PARIS NORD · FR
ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR

Inventors

Giuseppina Caligiuri · Paris, FR
Antonino Nicoletti · Paris, FR

Key dates

Filing date	Mar 15, 2013
Grant date	Jan 3, 2017
Priority date	—
Expiry date	Mar 15, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to various soluble forms of CD31, including a novel form which is shed by activated platelets and released into the circulation. Methods for detecting said soluble forms of CD31 are disclosed, as are methods of specifically 1 detecting said platelet-derived shed CD31 and the use of such methods as a diagnostic tool.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.